IDiyas

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Carey Horchler

USPTO Granted Patents = 7

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal7 out of 1,500 
 
Astrazeneca Ab
 patents

Years Active: 2004-2007

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7285662 - Therapeutic heterocyclic compounds (2007-10-23),
2. 7045514 - Therapeutic heterocyclic compounds (2006-05-16),
3. 7026314 - Therapeutic chromone compounds (2006-04-11),
4. 6946463 - 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain (2005-09-20),
5. 6933297 - 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain (2005-08-23),
6. 6833368 - 1, 2, 5, 10-tetrahydropyridazino[4, 5-b]quinoline-1,10-diones and their use for the treatment of pain (2004-12-21),
7. 6812225 - Therapeutic heterocyclic compounds (2004-11-02),

Title: Carey Horchler: Innovator in Therapeutic Compounds

Introduction

Carey Horchler is an accomplished inventor based in Wilmington, DE, known for her significant contributions to the field of therapeutic compounds. With a portfolio of seven patents, she has developed innovative solutions aimed at addressing various psychiatric and medical disorders, illustrating her commitment to enhancing healthcare.

Latest Patents

One of Horchler's latest patents focuses on therapeutic heterocyclic compounds, which are formulated to treat a range of psychiatric disorders, including depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. These compounds can also offer potential benefits for gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm, and sexual dysfunction. Notably, the compounds function as 5HT and 5HT antagonists, marking a substantial advancement in treatment options for these conditions.

Career Highlights

Carey Horchler is currently employed at AstraZeneca AB, a global biopharmaceutical company renowned for its innovative approach to medicine. Her role in patent development has been pivotal in the progression of therapeutic solutions, helping to shape modern healthcare practices through her research and inventions.

Collaborations

Throughout her career, Horchler has collaborated with esteemed colleagues, including Edward Pierson and Daniel Sohn. These partnerships reinforce the collaborative nature of innovation in the biopharmaceutical industry, where diverse expertise contributes to the development of groundbreaking treatments.

Conclusion

With her impressive track record of patents and her ongoing work at AstraZeneca AB, Carey Horchler continues to be a driving force in the field of therapeutic innovation. Her contributions not only advance medical science but also provide hope for patients facing challenging psychiatric and medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…